Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atlas Therapeutics Corp | 6,818,181 | reported | 13 Mar 2023 | tx 8+7,830,849 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Mar 2023 | PURCHASE | Atlas Therapeutics Corp | 6,818,181 | 0.32 USD | derivfirst after silence |
| 13 Mar 2023 | PURCHASE | Atlas Therapeutics Corp | 965,130 | 0.32 USD | deriv |
| 24 Dec 2020 | PURCHASE | Atlas Therapeutics Corp | 4,871 | 13.99 USD | |
| 22 Dec 2020 | PURCHASE | Atlas Therapeutics Corp | 7,661 | 13.70 USD | |
| 23 Dec 2020 | PURCHASE | Atlas Therapeutics Corp | 11,890 | 13.99 USD | |
| 24 Dec 2020 | PURCHASE | Atlas Therapeutics Corp | 4,019 | 13.99 USD | |
| 22 Dec 2020 | PURCHASE | Atlas Therapeutics Corp | 9,287 | 13.70 USD | |
| 23 Dec 2020 | PURCHASE | Atlas Therapeutics Corp | 9,810 | 13.99 USD |
1 purchase reported after at least 12 months of silence — most recent on 13 Mar 2023.